Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands

Cerebral Cortex

Volumn 11, Issue 12, 2001, Pages 1136-1143

  Cools, Roshan ^a   Barker, Roger A ^b   Sahakian, Barbara J ^c   Robbins, Trevor W ^a  

^a UK   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; SELEGILINE;

ARTICLE; ATTENTION; CAUDATE NUCLEUS; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG WITHDRAWAL; HUMAN; LEARNING; ORBITAL CORTEX; PARIETAL LOBE; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROBABILITY; TASK PERFORMANCE;

EID: 0035191059     PISSN: 10473211     EISSN: None     Source Type: Journal    
DOI: 10.1093/cercor/11.12.1136     Document Type: Article

References (62)

1. Anatomoclinical and biochemical concepts of subcortical dementia
2. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
3. Parallel organisation of functionally segregated circuits linking basal ganglia and cortex
4. Catecholamine modulation of prefrontal cortical cognitive function
5. On the control of control: The role of dopamine in regulating prefrontal function and working memory
6. Cognitive deficit caused by regional depletion of dopamine in the prefrontal cortex of rhesus monkeys
7. Reversal of antipsychotic induced working memory deficits by short-term dopamine D1 receptor stimulation
8. A theory of dopamine function and its role in cognitive deficits in schizophrenia
9. The effect of dopamine depletion from the caudate nucleus of the common marmoset (Callithrix jacchus) on tests of prefrontal cognitive function
10. Dissociation in prefrontal cortex of affective and attentional shifts
11. Behavioral effects of selective ablation of the caudate nucleus
12. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: Evidence for a specific attentional dysfunction
13. Effects of methylphenidate on spatial working memory and planning in healthy young adults
14. Unified Parkinson's Disease Rating Scale
15. 'Mini Mental State': A practical method for grading the cognitive state of patients for the clinician
16. D1 and D2 dopamine receptor regulation of striatonigral and striatopallidal neurons
17. Dopamine-mediated mechanisms of the prefrontal cortex
18. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa
19. Activation of dopamine cell firing by repeated L-Dopa administration to dopamine-depleted rats: Its potential role in mediating the therapeutic response to L-Dopa treatment
20. Towards a functional analysis of the basal ganglia
21. Parkinsonism: Onset, progression and mortality
22. Dopamine neurons report an error in the temporal prediction of reward during learning
23. The mechanisms of action of L-Dopa in Parkinson's disease
24. Limbic lesions and the problem of stimulusreinforcement associations
25. Effects of bromocriptine on human subjects depend on working memory capacity
26. Uneven patterns of dopamine loss in the striatum of patients with idiopathic Parkinson's disease
27. A neostriatal habit learningsystem in humans
28. Stimulant drugs and vigilance performance: A review
29. Role of dopamine in learning and memory: Implications for the treatment of cognitive dysfunction in patients with Parkinson's disease
30. Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels
31. L-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction
32. Discrimination, reversal, and shift learning in Huntington's disease: Mechanisms of impaired response selection
33. Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control
34. The metabolism of L-Dopa and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: Analysis of the intraventricular fluid from parkinsonian patients
35. Effects of dextro-amphetamine on cognitive performance and cortical activation
36. Systematic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease
37. Ritalin enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain
38. Improved short-term spatial memory but impaired reversal learning following the dopamine D2 agonist bromocriptine in human volunteers
39. The role of dorsolateral prefrontal cortex for executive cognitive processes in task switching
40. Idazoxan potentiates rather than antagonizes some of the cognitive effects of clonidine
41. Dissociable mechanisms of attentional control within the human prefrontal cortex
42. Fronto-striatal cognitive deficits at different stages of Parkinson's disease
43. Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease
44. Evidence for a two-stage model of spatial working memory processing within the lateral frontal cortex: A positron emission tomography study
45. Methods for measuring spontaneous motor activity
46. Dissociating executive mechanisms of task control following frontal lobe damage and Parkinson's disease
47. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: Implications for the monoaminergic basis of impulsive behaviour
48. Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans
49. The functions of the orbitofrontal cortex
50. The frontal lobe system: Cortical-subcortical interrelationships
51. Speed of behavior and its implications for cognition
52. Contextdependent activity in primate striatum reflecting past and future behavioral events
53. Reward processing in primate orbitofrontal cortex and basal ganglia
54. The role of prefrontal cortex and posterior parietal cortex in task switching
55. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: Possible adverse effects of dopaminergic medication
56. Frontal lobe dysfunction in Parkinson's disease
57. The role of locus coeruleus in the regulation of cognitive performance
58. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex
59. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance